2024 Conference Coverage
Playback speed
10 seconds
Multi-Institutional Study of Neurologic Outcomes in People With Multiple Sclerosis Who Are Treated With Immune Checkpoint Inhibitors (ICIs) for Oncologic Indications
0 views
May 8, 2024
Comments 1
Login to view comments.
Click here to Login
Videos